NCT03070522 - Prednisone in Cystic Fibrosis Pulmonary Exacerbations | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

October 7, 2023

Study Completion Date

October 7, 2023

Conditions

Cystic Fibrosis Pulmonary Exacerbation

Interventions

DRUG

Prednisone

oral prednisone for 7 days during pulmonary exacerbation

DRUG

Placebos

Placebo

Trial Locations (12)

T2N 4N1

The Governers of The University of Calgary - Alberta Health Services, Calgary

V6H 3N1

British Columbia Children's Hospital, Vancouver

V6Z 1Y6

St. Paul's Hospital, Vancouver

N6C 2R5

London Health Sciences Centre - Lawson Health Research Institute, London

K1H 8L6

The Ottawa Hospital, Ottawa

M5B 1W8

Unity Health Toronto - St. Michael's Hospital, Toronto

M5G1X8

SickKids, Toronto

H2X A09

The Centre hospitalier de l'Université de Montréal (CHUM), Montreal

H3T 1C5

Centre hospitalier universitaire Sainte-Justine, Montreal

G1R 2J6

CHU de Quebec-Universite Laval, Québec

G1V 4G5

Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval, Québec

S7N 0W8

University of Saskatchewan - Saskatchewan Health Authority, Saskatoon

All Listed Sponsors

collaborator

Canadian Cystic Fibrosis Foundation

OTHER

lead

The Hospital for Sick Children

OTHER